Adding a mineral filler to a polymer can create a composite material with properties tailored to specific application requirements.
But why add hydroxyapatite to a filament designed for medical 3D printing? And more importantly, what does it actually change?
At Lattice Services, several formulations combine resorbable polymers with hydroxyapatite, including PCL-HA and PLGA-HA.
Why combine a polymer with hydroxyapatite?
Hydroxyapatite is a calcium phosphate and one of the main mineral components of bone tissue.
It has been extensively studied in the field of biomaterials, particularly for applications involving bone regeneration and reconstruction.
When combined with a polymer, hydroxyapatite creates a composite material in which each component contributes to the overall properties and behavior of the material.
The polymer can provide properties such as processability, flexibility, and a specific resorption profile.
Hydroxyapatite, on the other hand, introduces a mineral phase that is particularly relevant for applications targeting bone tissue.
The goal is therefore not simply to add another component, but to combine complementary properties within a single material formulation.
PCL-HA: combining a resorbable polymer with a mineral phase
At Lattice Services, CAPROLACTISSE-HA combines PCL with 30 wt% hydroxyapatite.
This formulation combines the characteristics of PCL with a mineral phase designed for applications in bone reconstruction and tissue engineering.
PCL is known for its slow resorption rate and semi-flexible behavior.
Adding hydroxyapatite makes it possible to explore a formulation that differs from unfilled PCL, particularly for projects where incorporating a mineral phase is of interest.
PCL + hydroxyapatite = a slowly resorbing polymer matrix combined with a mineral phase.
PLGA-HA: another approach to composite materials
Lattice Services also offers GLYCOLACTISSE-HA, a PLGA formulation containing 10 wt% hydroxyapatite.
Here, the polymer matrix is different.
PLGA has its own mechanical, thermal, and resorption characteristics. Adding hydroxyapatite therefore results in a composite with an overall behavior that differs from a PCL-HA formulation.
This opens up different formulation possibilities by combining:
- the choice of polymer matrix
- the hydroxyapatite loading level
- the resorption profile
- the properties required for the final part
Does more hydroxyapatite mean better performance?
Not necessarily.
Hydroxyapatite content is just one of the formulation parameters that can influence the behavior of a composite material.
Changing the filler content can affect a range of material properties as well as its processability during filament extrusion and 3D printing.
The right formulation should therefore be selected according to the project’s specific requirements, including the desired material properties, part geometry, manufacturing process, and intended application.
There is no universally optimal hydroxyapatite content for every application.
From filament to medical device: the formulation is only part of the equation
Once a filament is converted into a 3D-printed part, other factors come into play.
Geometry, wall thickness, porosity, internal architecture, and printing parameters can all influence the properties and performance of the final structure.
As a result, the same material can behave differently depending on how the final part is designed and manufactured.
For medical applications, material selection and design should therefore be considered as complementary aspects of the development process.
What if the formulation needs to be tailored to the project?
Not every project requires a standard formulation.
The polymer matrix, hydroxyapatite loading level, or specific filament characteristics may need to be defined according to the project’s requirements from the earliest stages of development.
At Lattice Services, our extrusion capabilities also allow us to explore customized formulations for specific technical requirements.
The right composite depends on the application
Adding hydroxyapatite to a polymer is not simply about “improving” a filament.
It is about designing a composite formulation in which the different components work together to meet the requirements of the intended application.
PCL-HA and PLGA-HA illustrate two different approaches, combining different polymer matrices with different hydroxyapatite loading levels.
The right composite material should be selected based on the properties required for the final medical device and the constraints of its manufacturing process.
